Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar
Hiam Chemaitelly, Houssein H. Ayoub, Sawsan AlMukdad, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong: a population-based observational study
Martina McMenamin, Joshua Nealon, Yun Lin, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 10, pp. 1435-1443
Open Access | Times Cited: 315
Protection of COVID-19 vaccination and previous infection against Omicron BA.1, BA.2 and Delta SARS-CoV-2 infections
Stijn P. Andeweg, Brechje de Gier, Dirk Eggink, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 118
Recall of preexisting cross-reactive B cell memory after Omicron BA.1 breakthrough infection
Chengzi I. Kaku, Alan Bergeron, Clas Ahlm, et al.
Science Immunology (2022) Vol. 7, Iss. 73
Open Access | Times Cited: 116
SARS-CoV-2 Omicron Variant: Epidemiological Features, Biological Characteristics, and Clinical Significance
Yifei Guo, Jiajia Han, Yao Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 101
The Importance of Vaccination in the Context of the COVID-19 Pandemic: A Brief Update Regarding the Use of Vaccines
Bruna Aparecida Souza Machado, Katharine Valéria Saraiva Hodel, Larissa Moraes dos Santos Fonseca, et al.
Vaccines (2022) Vol. 10, Iss. 4, pp. 591-591
Open Access | Times Cited: 63
Magnitude of venous or capillary blood-derived SARS-CoV-2-specific T cell response determines COVID-19 immunity
Martin Scurr, George Lippiatt, Lorenzo Capitani, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 50
Effect of prior infection, vaccination, and hybrid immunity against symptomatic BA.1 and BA.2 Omicron infections and severe COVID-19 in Qatar
Heba N. Altarawneh, Hiam Chemaitelly, Houssein H. Ayoub, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 40
Immunocompromise and durability of BNT162b2 vaccine against severe outcomes due to omicron and delta variants
Sara Y. Tartof, Jeff Slezak, Laura Puzniak, et al.
The Lancet Respiratory Medicine (2022) Vol. 10, Iss. 7, pp. e61-e62
Open Access | Times Cited: 33
Vaccine Effectiveness of Two and Three Doses of BNT162b2 and Coronavac Against COVID-19 in Hong Kong
Martina McMenamin, Joshua Nealon, Yun Lin, et al.
SSRN Electronic Journal (2022)
Open Access | Times Cited: 31
Vaccine effectiveness of two and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong
Martina McMenamin, Joshua Nealon, Yun Lin, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 31
The emergence of SARS-CoV-2 Omicron subvariants: current situation and future trends
Ramadan Abdelmoez Farahat, Abdelaziz Abdelaal, Tungki Pratama Umar, et al.
Infezioni in Medicina (2022) Vol. 30, Iss. 4
Open Access | Times Cited: 30
Performance of Antigen Detection Tests for SARS-CoV-2: A Systematic Review and Meta-Analysis
Anastasia Tapari, Georgia G. Braliou, Maria Papaefthimiou, et al.
Diagnostics (2022) Vol. 12, Iss. 6, pp. 1388-1388
Open Access | Times Cited: 27
Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland—A multicentre cohort study
Baharak Babouee Flury, Sabine Güsewell, Thomas Egger, et al.
PLoS Medicine (2022) Vol. 19, Iss. 11, pp. e1004125-e1004125
Open Access | Times Cited: 23
Immuno-Epidemiological Model-Based Prediction of Further Covid-19 Epidemic Outbreaks Due to Immunity Waning
Samiran Ghosh, Malay Banerjee, Vitaly Volpert
Mathematical Modelling of Natural Phenomena (2022) Vol. 17, pp. 9-9
Open Access | Times Cited: 16
All-Cause Mortality According to COVID-19 Vaccination Status: an analysis of the UK Office for National Statistics Public Data
Alberto Donzelli, Giovanni Malatesta, Giovanni Di Palmo, et al.
(2023)
Open Access | Times Cited: 9
Protection of COVID-19 vaccination and previous infection against Omicron BA.1, BA.2 and Delta SARS-CoV-2 infections
Stijn P. Andeweg, Brechje de Gier, Dirk Eggink, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 15
Effectiveness of influenza vaccination against SARS-CoV-2 infection among healthcare workers in Qatar
Elias Tayar, Sami Abdeen, Muna Abed Alah, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 14
Behavioural insights and the evolving COVID-19 pandemic
Marijn de Bruin, Jonathan E. Suk, Marianna Baggio, et al.
Eurosurveillance (2022) Vol. 27, Iss. 18
Open Access | Times Cited: 13
Protection of prior natural infection compared to mRNA vaccination against SARS-CoV-2 infection and severe COVID-19 in Qatar
Hiam Chemaitelly, Houssein H. Ayoub, Sawsan AlMukdad, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 12
Association between primary or booster COVID-19 mRNA vaccination and Omicron lineage BA.1 SARS-CoV-2 infection in people with a prior SARS-CoV-2 infection: A test-negative case–control analysis
Margaret L. Lind, Alexander J. Robertson, Julio Silva, et al.
PLoS Medicine (2022) Vol. 19, Iss. 12, pp. e1004136-e1004136
Open Access | Times Cited: 12
The Omicron-transformer: Rise of the subvariants in the age of vaccines
Travis Ren Teen Chia, Barnaby Edward Young, Po Ying Chia
Annals of the Academy of Medicine Singapore (2022) Vol. 51, Iss. 11, pp. 712-729
Open Access | Times Cited: 10
Recall of pre-existing cross-reactive B cell memory following Omicron breakthrough infection
Chengzi I. Kaku, Alan Bergeron, Clas Ahlm, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 6
Contribution of low population immunity to the severe Omicron BA.2 outbreak in Hong Kong
Lin‐Lei Chen, Syed Muhammad Umer Abdullah, Wan-Mui Chan, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 6
Long Term Assessment of Anti-SARS-CoV-2 Immunogenicity after mRNA Vaccine in PLWH
Alessandra Vergori, Alessandro Cozzi‐Lepri, Giulia Matusali, et al.
(2023)
Open Access | Times Cited: 3
mRNA vaccine effectiveness against hospitalisation due to severe acute respiratory infection (SARI) COVID-19 during Omicron variant predominance estimated from real-world surveillance data, Slovenia, February to March 2022
Marta Grgič Vitek, Irena Klavs, Veronika Učakar, et al.
Eurosurveillance (2022) Vol. 27, Iss. 20
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top